Antimelanoma differentiation-associated gene 5 dermatomyositis associated with acute encephalopathy

Antimelanoma differentiation-associated gene 5 dermatomyositis associated with acute encephalopathy

Bibliographic Details
Main Authors:	Morgan Nguyen, BA, Jacob Groenendyk, MD, Danielle Steker, MD, Parul Kathuria Goyal, MD, Cuong V. Nguyen, MD
Format:	Article
Language:	English
Published:	Elsevier 2021-07-01
Series:	JAAD Case Reports
Subjects:	connective tissue disease dermatomyositis encephalopathy interstitial lung disease medical dermatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512621002873

Similar Items

Erythromelalgia associated with dermatomyositis: A case series
by: Madison Grinnell, BA, et al.
Published: (2021-10-01)

Serum progranulin level is a novel tool for monitoring disease activity of dermatomyositis with antimelanoma differentiation‐associated protein 5 antibodies
by: Asami Fujii, et al.
Published: (2021-06-01)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
by: Yumiko Sugiyama, et al.
Published: (2018-01-01)

Rapidly progressive melanoma differentiation–associated protein 5–positive amyopathic dermatomyositis in an HIV-positive patient
by: Ashutosh Sharma, BSc, et al.
Published: (2017-03-01)

Resistin Expression Is Associated With Interstitial Lung Disease in Dermatomyositis
by: Lifang Ye, et al.
Published: (2022-05-01)

Clinical nomogram assisting in discrimination of juvenile dermatomyositis-associated interstitial lung disease
by: Minfei Hu, et al.
Published: (2023-11-01)

Adrenomedullin Expression Is Associated With the Severity and Poor Prognosis of Interstitial Lung Disease in Dermatomyositis Patients
by: Lifang Ye, et al.
Published: (2022-06-01)

Wong-Type Dermatomyositis: An Extremely Rare Disease in Childhood
by: Mario Diplomatico, et al.
Published: (2019-10-01)

Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis
by: Stefano Palmucci, et al.
Published: (2022-11-01)

Amyopathic Dermatomyositis Associated with Histopathological Findings of Organizing Pneumonia and Pulmonary Vasculitis
by: Jeong Uk Lim, et al.
Published: (2017-08-01)

Dermatomyositis associated with hyponatremia and anasarca
by: Madison Grinnell, BA, et al.
Published: (2021-10-01)

Efficacy of topical ruxolitinib for cutaneous dermatomyositis
by: Aviya Lanis, MD, et al.
Published: (2024-03-01)

Paraneoplastic Wong-Type Dermatomyositis Associated with Gynecological Malignancy
by: Roberto Russo, et al.
Published: (2022-03-01)

Melanoma differentiation-associated gene 5 amyopathic dermatomyositis following an acute Mycoplasma pneumoniae infection: a case report
by: Jessica Hoey, et al.
Published: (2022-11-01)

Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study
by: Shuang Zhou, et al.
Published: (2022-08-01)

Disease-associated immune cell endotypes in anti-MDA5-positive dermatomyositis using unbiased hierarchical clustering
by: Ruru Guo, et al.
Published: (2024-03-01)

Diffuse large B‐cell lymphoma in a patient with dermatomyositis‐associated interstitial lung disease: A case report
by: Shan Li, et al.
Published: (2019-10-01)

A Case Report of Fabry Disease Associated with Dermatomyositis
by: ZHOU Yi, et al.
Published: (2023-01-01)

Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis
by: Yulu Qiu, et al.
Published: (2024-01-01)

Dermatomyositis associated with an adrenal adenoma
by: Sherif A. Eldirany, BS, et al.
Published: (2021-06-01)

Use of anti-B-cell therapy in case of antisynthetase syndrome as the severest subtype of polymyositis/dermatomyositis
by: O A Antelava, et al.
Published: (2014-05-01)

Soluble CD206 levels correlate with disease deterioration and predict prognosis of anti‐MDA5 antibody‐positive dermatomyositis related interstitial lung disease
by: Yan Li, et al.
Published: (2023-06-01)

Efficiency of Therapeutic Plasma-Exchange in Acute Interstitial Lung Disease, Associated With Polymyositis/Dermatomyositis Resistant to Glucocorticoids and Immunosuppressive Drugs: A Retrospective Study
by: Yaogui Ning, et al.
Published: (2019-11-01)

Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis
by: Yuichi Ishikawa, et al.
Published: (2018-10-01)

Successful treatment of thymic carcinoma with dermatomyositis and interstitial pneumonia: A case report
by: Xingguo Yang, et al.
Published: (2019-10-01)

Dermatomiosite Dermatomyositis
by: Luciena Cegatto Martins Ortigosa, et al.
Published: (2008-06-01)

Serum levels of interleukins and S100A8/A9 correlate with clinical severity in patients with dermatomyositis-associated interstitial lung disease
by: Yueyan Lou, et al.
Published: (2020-07-01)

Fatal rapidly progressive interstitial lung disease in a patient with amyopathic dermatomyositis
by: Abdullah Mobeireek, et al.
Published: (2021-01-01)

Recurrence of juvenile dermatomyositis 8 years after remission
by: Ken Muramatsu, MD, et al.
Published: (2017-01-01)

Therapeutic options in refractory anti-MDA5 dermatomyositis triggered by SARS-CoV-2 infection
by: Elena Juganaru, et al.
Published: (2022-09-01)

Juvenile dermatomyositis: is periodontal disease associated with dyslipidemia?
by: Kátia T. Kozu, et al.
Published: (2018-09-01)

Overlap of dermatomyositis and cutaneous lupus erythematosus: A case series
by: Rachita Pandya, BA, et al.
Published: (2023-12-01)

Refractory dermatomyositis responsive to anifrolumab
by: Phillip S. Ang, BA, et al.
Published: (2024-01-01)

Dermatomyositis as a manifestation of cancer
by: Katarzyna Przekazińska-Boager, et al.
Published: (2014-03-01)

Clinical features and prognostic factors of anti‐melanoma differentiation‐associated gene 5 antibody‐positive dermatomyositis with rapidly progressive interstitial lung disease in Chinese patients
by: Li Lian, et al.
Published: (2023-06-01)

Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case-control study
by: Qiang Ji, et al.
Published: (2023-11-01)

Case report: Successful treatment of anti‐MDA5‐positive to negative dermatomyositis‐associated interstitial lung disease with the JAK inhibitor tofacitinib
by: Zong Jiang, et al.
Published: (2023-06-01)

Respiratory symptoms as initial manifestations of interstitial lung disease in clinically amyopathic juvenile dermatomyositis: a case report with literature review
by: Jingyi Xia, et al.
Published: (2021-11-01)

Case Report: Extracorporeal Membrane Oxgenation for Rapidly Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis in a Post-partum Woman
by: Qiao Gu, et al.
Published: (2021-10-01)

Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case–Control Study
by: Chenghua Weng, et al.
Published: (2023-02-01)